Ashland Inc. (ASH)
NYSE: ASH · Real-Time Price · USD
50.50
-1.06 (-2.06%)
Aug 1, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2014 - 2019 |
Life Sciences | 810.00M | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences Growth | -17.89% | Log In | Log In | Log In | Log In | Upgrade |
Personal Care | 634.00M | Log In | Log In | Log In | Log In | Upgrade |
Personal Care Growth | 4.58% | Log In | Log In | Log In | Log In | Upgrade |
Specialty Additives | 572.00M | Log In | Log In | Log In | Log In | Upgrade |
Specialty Additives Growth | -5.57% | Log In | Log In | Log In | Log In | Upgrade |
Intermediates | 144.00M | Log In | Log In | Log In | Log In | Upgrade |
Intermediates Growth | -7.19% | Log In | Log In | Log In | Log In | Upgrade |
Eliminations from | -47.00M | Log In | Log In | Log In | Log In | Upgrade |
Eliminations from Growth | -10.00% | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2014 - 2019 |
Other | 197.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 1635.29% | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences Operating Income | 168.00M | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences Operating Income Growth | -20.99% | Log In | Log In | Log In | Log In | Upgrade |
Personal Care Operating Income | 73.00M | Log In | Log In | Log In | Log In | Upgrade |
Personal Care Operating Income Growth | 52.73% | Log In | Log In | Log In | Log In | Upgrade |
Specialty Additives Operating Income | -32.00M | Log In | Log In | Log In | Log In | Upgrade |
Specialty Additives Operating Income Growth | -136.84% | Log In | Log In | Log In | Log In | Upgrade |
Intermediates Operating Income | 29.00M | Log In | Log In | Log In | Log In | Upgrade |
Intermediates Operating Income Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 197.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 1635.29% | Log In | Log In | Log In | Log In | Upgrade |
Unallocated and Other Operating Income | -264.00M | Log In | Log In | Log In | Log In | Upgrade |
Unallocated and Other Operating Income Growth | 202.24% | Log In | Log In | Log In | Log In | Upgrade |
EBITDA by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2014 - 2019 |
Life Sciences EBITDA | 229.00M | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences EBITDA Growth | -13.10% | Log In | Log In | Log In | Log In | Upgrade |
Personal Care EBITDA | 152.00M | Log In | Log In | Log In | Log In | Upgrade |
Personal Care EBITDA Growth | 14.49% | Log In | Log In | Log In | Log In | Upgrade |
Specialty Additives EBITDA | 89.00M | Log In | Log In | Log In | Log In | Upgrade |
Specialty Additives EBITDA Growth | 42.42% | Log In | Log In | Log In | Log In | Upgrade |
Intermediates EBITDA | 42.00M | Log In | Log In | Log In | Log In | Upgrade |
Intermediates EBITDA Growth | -31.71% | Log In | Log In | Log In | Log In | Upgrade |
Unallocated and Other EBITDA | -264.00M | Log In | Log In | Log In | Log In | Upgrade |
Unallocated and Other EBITDA Growth | 202.24% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2014 - 2019 |
United States | 624.00M | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | - | Log In | Log In | Log In | Log In | Upgrade |
International | 1.49B | Log In | Log In | Log In | Log In | Upgrade |
International Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2014 - 2019 |
Change in Sales Due to Volume | 1.00M | Log In | Log In | Log In | Log In | Upgrade |
Change in Sales Due to Volume Growth | -820.00% | Log In | Log In | Log In | Log In | Upgrade |
Change in Sales Due to Product Pricing/Mix | -78.00M | Log In | Log In | Log In | Log In | Upgrade |
Change in Sales Due to Product Pricing/Mix Growth | -58.06% | Log In | Log In | Log In | Log In | Upgrade |